4 Ways You Can Have a Low Credit Score Despite Paying Your Bills on Time

4 Ways You Can Have a Low Credit Score Despite Paying Your Bills on Time

Whether you realize it or not, your credit score can have a major impact on more than just your finances. We often think of our credit score as influencing our ability to get a mortgage, take out a loan, or open a new credit account. But your credit score (also known as FICO score), which → Read More

1 Quote Reveals Why Gilead Sciences Hasn't Bought Anybody Yet

1 Quote Reveals Why Gilead Sciences Hasn't Bought Anybody Yet

Gilead Sciences (NASDAQ:GILD) needs to buy somebody.  The Hepatitis C / HIV behemoth has seen its price tank in 2016 as investor fears about growth slowing — and even reversing — have come true. Slashing prices to maintain its Hepatitis C market share has dramatically impacted Gilead's top line, with overall revenue falling 9.6% year → Read More

Here's Why Amyris Stock Dropped 16.8% in November

Here's Why Amyris Stock Dropped 16.8% in November

What happened After a meteoric 220% rise from August to mid-October, shares of Amyris (NASDAQ:AMRS) fell 16.8% in November. A flurry of announced deals and partnership agreements weren't enough to overcome the reality of the company's financial performance. So what The company reported third-quarter 2016 earnings on Nov. 2. At first glance, there was plenty → Read More

Why Smith & Wesson and Sturm, Ruger Stocks Sank in November

Why Smith & Wesson and Sturm, Ruger Stocks Sank in November

What happened November was a strange month for gun stocks. Over the course of last month, shares of two of the biggest names in guns — Smith & Wesson (NASDAQ:SWHC) and Sturm, Ruger (NYSE:RGR) — both declined sharply. According to data from S&P Global Market Intelligence, Smith & Wesson stock dropped 10.5% in November, while → Read More

Can Skechers Stock Keep Going After Last Week's 18% Pop?

Can Skechers Stock Keep Going After Last Week's 18% Pop?

The bulls got the better of the battle at Skechers (NYSE:SKX) last week. Shares of the footwear maker moved 18.2% higher, winning investors after insider buying and an analyst upgrade. The week began with CEO Robert Greenberg adding to his position, snapping up another 500,000 shares between Monday and Tuesday. The roughly $11 million transaction is notable because it's his → Read More

Venezuela is printing a 20,000 bolivar note

Venezuela is printing a 20,000 bolivar note

Venezuelans cross into Colombia to get food Venezuela will print a 20,000 bolivar note after hyperinflation turned its currency into worthless pieces of paper. The central bank said Sunday it will issue six new bills starting Dec. 15 worth between 500 and 20,000 bolivars. That's 200 times the biggest note currently in circulation — the → Read More

Why Celgene Shares Jumped 13.9% In November

Why Celgene Shares Jumped 13.9% In November

What happened Following the election of Donald Trump as the next U.S. president and ahead of intriguing early stage data out of one of its collaboration partners, shares in Celgene Corp. (NASDAQ:CELG) rallied 13.9% last month, according to S&P Global Market Intelligence. So what President-elect Trump's victory on Nov. 8 is being widely viewed by industry watchers as a → Read More

Why is Warren Buffett Investing in Airlines?

Why is Warren Buffett Investing in Airlines?

Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) recently invested in four of America's largest airline companies — seemingly going against Warren Buffett's often-stated distaste for any investment in the airline industry. In this week's episode of Industry Focus: Energy, Motley Fool analyst Sean O'Reilly and Fool contributor Adam Levine-Weinberg explain why the company is finally investing in the industry, → Read More

The Smartest Tax Move to Make in 2017

The Smartest Tax Move to Make in 2017

There are literally thousands of moves you can make to lower your taxes and make your tax season easier. However, maximizing your tax-advantaged retirement accounts is perhaps the best tax move of all. Not only do these accounts get you a nice tax break at the end of the year, but they can also set → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.